Selected research
Industry Research
Prothrombin Complex Concentrates Industry Research Report 2026
Market perspective
The global Prothrombin Complex Concentrates market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prothrombin Complex Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prothrombin Complex Concentrates is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prothrombin Complex Concentrates is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prothrombin Complex Concentrates include Takeda, Grifols, Octapharma AG and CSL Behring GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prothrombin Complex Concentrates market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prothrombin Complex Concentrates Market by Company
Takeda
Grifols
Octapharma AG
CSL Behring GmbH
Prothrombin Complex Concentrates Segment by Type
3F Prothrombin Complex Concentrates
4F Prothrombin Complex Concentrates
Prothrombin Complex Concentrates Segment by Application
Hospital Pharmacies
Retail Pharmacies
Compound Pharmacies
Prothrombin Complex Concentrates Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prothrombin Complex Concentrates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prothrombin Complex Concentrates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 3F Prothrombin Complex Concentrates
- 4F Prothrombin Complex Concentrates
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Compound Pharmacies
Companies covered
- Takeda
- Grifols
- Octapharma AG
- CSL Behring GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prothrombin Complex Concentrates Market Size (2021-2032)
- 2.2.2 Global Prothrombin Complex Concentrates Sales (2021-2032)
- 2.2.3 Global Prothrombin Complex Concentrates Market Average Price (2021-2032)
- 2.3 Prothrombin Complex Concentrates by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 3F Prothrombin Complex Concentrates
- 2.3.3 4F Prothrombin Complex Concentrates
- 2.4 Prothrombin Complex Concentrates by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Compound Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prothrombin Complex Concentrates Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prothrombin Complex Concentrates Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Prothrombin Complex Concentrates Revenue of Manufacturers (2021-2026)
- 3.4 Global Prothrombin Complex Concentrates Average Price by Manufacturers (2021-2026)
- 3.5 Global Prothrombin Complex Concentrates Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prothrombin Complex Concentrates, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prothrombin Complex Concentrates, Product Type & Application
- 3.8 Global Manufacturers of Prothrombin Complex Concentrates, Established Date
- 3.9 Global Prothrombin Complex Concentrates Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Prothrombin Complex Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Prothrombin Complex Concentrates Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Grifols
- 4.2.1 Grifols Company Information
- 4.2.2 Grifols Business Overview
- 4.2.3 Grifols Prothrombin Complex Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grifols Prothrombin Complex Concentrates Product Portfolio
- 4.2.5 Grifols Recent Developments
- 4.3 Octapharma AG
- 4.3.1 Octapharma AG Company Information
- 4.3.2 Octapharma AG Business Overview
- 4.3.3 Octapharma AG Prothrombin Complex Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Octapharma AG Prothrombin Complex Concentrates Product Portfolio
- 4.3.5 Octapharma AG Recent Developments
- 4.4 CSL Behring GmbH
- 4.4.1 CSL Behring GmbH Company Information
- 4.4.2 CSL Behring GmbH Business Overview
- 4.4.3 CSL Behring GmbH Prothrombin Complex Concentrates Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CSL Behring GmbH Prothrombin Complex Concentrates Product Portfolio
- 4.4.5 CSL Behring GmbH Recent Developments
5 Global Prothrombin Complex Concentrates Market Scenario by Region
- 5.1 Global Prothrombin Complex Concentrates Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prothrombin Complex Concentrates Sales by Region: 2021-2032
- 5.2.1 Global Prothrombin Complex Concentrates Sales by Region: 2021-2026
- 5.2.2 Global Prothrombin Complex Concentrates Sales by Region: 2027-2032
- 5.3 Global Prothrombin Complex Concentrates Revenue by Region: 2021-2032
- 5.3.1 Global Prothrombin Complex Concentrates Revenue by Region: 2021-2026
- 5.3.2 Global Prothrombin Complex Concentrates Revenue by Region: 2027-2032
- 5.4 North America Prothrombin Complex Concentrates Market Facts & Figures by Country
- 5.4.1 North America Prothrombin Complex Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 5.4.3 North America Prothrombin Complex Concentrates Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prothrombin Complex Concentrates Market Facts & Figures by Country
- 5.5.1 Europe Prothrombin Complex Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 5.5.3 Europe Prothrombin Complex Concentrates Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prothrombin Complex Concentrates Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prothrombin Complex Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prothrombin Complex Concentrates Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prothrombin Complex Concentrates Market Facts & Figures by Country
- 5.7.1 South America Prothrombin Complex Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 5.7.3 South America Prothrombin Complex Concentrates Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Prothrombin Complex Concentrates Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prothrombin Complex Concentrates Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prothrombin Complex Concentrates Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prothrombin Complex Concentrates Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prothrombin Complex Concentrates Sales by Type (2021-2032)
- 6.1.1 Global Prothrombin Complex Concentrates Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Prothrombin Complex Concentrates Sales Market Share by Type (2021-2032)
- 6.2 Global Prothrombin Complex Concentrates Revenue by Type (2021-2032)
- 6.2.1 Global Prothrombin Complex Concentrates Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prothrombin Complex Concentrates Revenue Market Share by Type (2021-2032)
- 6.3 Global Prothrombin Complex Concentrates Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prothrombin Complex Concentrates Sales by Application (2021-2032)
- 7.1.1 Global Prothrombin Complex Concentrates Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Prothrombin Complex Concentrates Sales Market Share by Application (2021-2032)
- 7.2 Global Prothrombin Complex Concentrates Revenue by Application (2021-2032)
- 7.2.1 Global Prothrombin Complex Concentrates Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prothrombin Complex Concentrates Revenue Market Share by Application (2021-2032)
- 7.3 Global Prothrombin Complex Concentrates Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prothrombin Complex Concentrates Value Chain Analysis
- 8.1.1 Prothrombin Complex Concentrates Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prothrombin Complex Concentrates Production Mode & Process
- 8.2 Prothrombin Complex Concentrates Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prothrombin Complex Concentrates Distributors
- 8.2.3 Prothrombin Complex Concentrates Customers
9 Global Prothrombin Complex Concentrates Analyzing Market Dynamics
- 9.1 Prothrombin Complex Concentrates Industry Trends
- 9.2 Prothrombin Complex Concentrates Industry Drivers
- 9.3 Prothrombin Complex Concentrates Industry Opportunities and Challenges
- 9.4 Prothrombin Complex Concentrates Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst